Phase 1 13 trials
Phase 1
NCT02389751 Apr 2015 → Jul 2019 gastroesophageal junction adenocarcinoma , malignant neoplasm of cervical esophagus , malignant neoplasm of thoracic esophagus M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT02192541 Dec 2014 → Feb 2016 neoplasm National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT02334319 Dec 2014 → Feb 2016 hypopharynx squamous cell carcinoma , laryngeal squamous cell carcinoma , oral cavity squamous cell carcinoma , oropharynx squamous cell carcinoma Emory University
Terminated
No outcome recorded
Phase 1
NCT02060253 Apr 2014 → Jun 2018 HER2 positive breast carcinoma , male breast carcinoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT01554969 May 2012 → Mar 2015 rectal cancer Emory University
Completed
No outcome recorded
Phase 1
NCT01579994 Apr 2012 → Dec 2020 lung cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT01485835 Jan 2012 → Sep 2015 plasma cell myeloma Emory University
Completed
No outcome recorded
Phase 1
NCT01665937 Aug 2010 → Jul 2013 hepatocellular carcinoma Massachusetts General Hospital
Completed
No outcome recorded
Phase 1
NCT01183364 Jul 2010 → Mar 2013 —
Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Phase 1
NCT00964873 Aug 2009 → Dec 2010 acute lymphoblastic leukemia , acute myeloid leukemia , blast phase chronic myelogenous leukemia, BCR-ABL1 positive Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Phase 1
NCT00858572 Mar 2009 → May 2011 acute myeloid leukemia , chronic myeloid leukemia , myelodysplastic syndrome Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Phase 1
NCT00688116 Oct 2007 → Apr 2014 cancer Synta Pharmaceuticals Corp.
Unknown
No outcome recorded
Phase 1
NCT00687934 Oct 2007 → Jun 2011 cancer Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Show 3 more trials Phase 1/2 6 trials
Phase 1/2
NCT02261805 Oct 2014 → Oct 2016 small cell lung carcinoma Georgetown University
Terminated
No outcome recorded
Phase 1/2
NCT02012192 Jul 2014 → Nov 2017 fallopian tube carcinoma , malignant epithelial tumor of ovary , primary peritoneal carcinoma Medical University Innsbruck
Terminated
No outcome recorded
Phase 1/2
NCT02008877 Dec 2013 → Apr 2018 malignant peripheral nerve sheath tumor Sarcoma Alliance for Research through Collaboration
Completed
No outcome recorded
Phase 1/2
NCT01962948 Oct 2013 → May 2016 fallopian tube cancer , malignant epithelial tumor of ovary , primary peritoneal carcinoma Fox Chase Cancer Center
Terminated
No outcome recorded
Phase 1/2
NCT01590160 Aug 2013 → Nov 2019 malignant pleural mesothelioma University College, London
Completed
No outcome recorded
Phase 1/2
NCT01236144 Apr 2011 → Dec 2013 acute myeloid leukemia , myelodysplastic syndrome Cardiff University
Completed
No outcome recorded
Phase 2 15 trials
Phase 2
NCT03783949 Nov 2018 → Sep 2023 fallopian tube cancer , ovarian cancer , primary peritoneal carcinoma Universitaire Ziekenhuizen KU Leuven
Completed
No outcome recorded
Phase 2
NCT01677455 Jul 2012 → Apr 2015 HER2 positive breast carcinoma , triple-negative breast carcinoma Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Phase 2
NCT01562015 Apr 2012 → Aug 2014 non-small cell lung carcinoma Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Phase 2
NCT01551693 Sep 2011 → Sep 2012 melanoma Dana-Farber Cancer Institute
Terminated
No outcome recorded
Phase 2
NCT01368003 Apr 2011 → Nov 2012 prostate adenocarcinoma Toni Choueiri, MD
Withdrawn
No outcome recorded
Phase 2
NCT01273896 Jan 2011 → Sep 2013 breast cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT01270880 Jan 2011 → Jul 2014 hormone-resistant prostate carcinoma , prostate adenocarcinoma Barbara Ann Karmanos Cancer Institute
Completed
No outcome recorded
Phase 2
NCT01227018 Dec 2010 → May 2013 pancreatic adenocarcinoma Vanderbilt-Ingram Cancer Center
Terminated
No outcome recorded
Phase 2
NCT01200238 Sep 2010 → Oct 2014 ocular melanoma Dana-Farber Cancer Institute
Completed
No outcome recorded
Phase 2
NCT01167114 Aug 2010 → May 2016 gastroesophageal cancer Massachusetts General Hospital
Completed
No outcome recorded
Phase 2
NCT01173523 Jul 2010 → Jun 2013 small cell lung carcinoma David M. Jackman, MD
Completed
No outcome recorded
Phase 2
NCT01111838 Apr 2010 → Jul 2012 rectal cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT01042379 Mar 2010 → Dec 2030 expected HER2 positive breast carcinoma , angiosarcoma , female breast carcinoma , hormone receptor-positive breast cancer +1 QuantumLeap Healthcare Collaborative
Recruiting
No outcome recorded
Phase 2
NCT01039519 Jan 2010 → Dec 2011 gastrointestinal stromal tumor Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Phase 2
NCT01031225 Nov 2009 → Jul 2013 non-small cell lung carcinoma Synta Pharmaceuticals Corp.
Completed
No outcome recorded
Show 5 more trials Phase 2/3 1 trial
Phase 2/3
NCT01348126 May 2011 → Apr 2014 non-small cell lung carcinoma Synta Pharmaceuticals Corp.
Terminated
No outcome recorded
Phase 3 1 trial
Phase 3
NCT01798485 Apr 2013 → Dec 2015 lung adenocarcinoma Synta Pharmaceuticals Corp.
Terminated
No outcome recorded
Phase not applicable 1 trial
— NCT02637375 May 2016 → Dec 2018 breast cancer University of Chicago
Withdrawn
No outcome recorded